Exploring the role of a novel postbiotic bile acid: Interplay with gut microbiota, modulation of the farnesoid X receptor, and prospects for clinical translation
Microbiological Research,
Journal Year:
2024,
Volume and Issue:
287, P. 127865 - 127865
Published: Aug. 6, 2024
Language: Английский
Ginsenoside Rg1 Enriches Gut Microbial Indole-3-acetic acid to Alleviate Depression-like Behavior in Mice via Oxytocin Signaling
Siqi Yu,
No information about this author
Zhe Yin,
No information about this author
Ming Ling
No information about this author
et al.
Phytomedicine,
Journal Year:
2024,
Volume and Issue:
135, P. 156186 - 156186
Published: Oct. 28, 2024
Language: Английский
Traditional Chinese medicine Yiqi Huoxue Huatan recipe inhibits atherosclerosis by regulating intestinal flora and its associated metabolites
Hongtao Huang,
No information about this author
Wei Lv,
No information about this author
Hanjun Zhao
No information about this author
et al.
Pharmacological Research - Modern Chinese Medicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100593 - 100593
Published: Feb. 1, 2025
Language: Английский
Systemic lupus erythematosus and atherosclerosis: immune pathways and the uncharted territory of gut microbiota and metabolism
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 28, 2025
Patients
with
Systemic
Lupus
Erythematosus
(SLE)
are
significantly
more
susceptible
to
atherosclerosis,
which
may
elevate
their
mortality
risk.
The
review
explores
recent
understandings
of
the
origins
and
remedies
for
atherosclerosis
associated
SLE.
Our
focus
is
particularly
on
consequences
immune
system
disparities,
interruptions
in
intestinal
bacteria,
metabolic
complications.
influence
SLE
extends
past
usual
risk
elements,
including
processes
specific
disease.
list
encompasses
excessive
cell
activity,
production
autoantibodies,
inflammatory
responses.
A
variety
therapies
linked
encompass
cholesterol-lowering
medications,
anti-inflammatory
drugs,
suppressors,
antimalarials,
interferon
treatments,
NET
inhibitors,
methods
aimed
at
T
B-cells.
However,
existing
research
has
its
shortcomings,
necessitating
additional
clinical
trials
ascertain
efficacy
security
these
therapies.
direct
interactions
among
SLE,
gut
microbiota,
metabolism,
underexplored,
presenting
innovation
opportunities.
Research
into
microbial
strains
metabolites’
effects
responses
progression
patients
needed.
Such
could
uncover
novel
therapeutic
targets
biomarkers,
advancing
prevention
treatment
strategies
cardiovascular
Language: Английский
Metformin’s dual impact on Gut microbiota and cardiovascular health: A comprehensive analysis
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
178, P. 117128 - 117128
Published: July 29, 2024
Cardiovascular
diseases
(CVD)
cause
significant
global
morbidity,
mortality
and
public
health
burden
annually.
CVD
alters
richness,
diversity,
composition
of
Gut
microbiota
along
with
RAS
histopathological
differences.
Present
study
explores
Metformin
role
in
mitigating
doxorubicin
induced
cardiovascular
toxicity/remodeling.
Animals
were
divided
into
4
groups
n=6:
Group
I
(N.
Control)
free
access
to
diet
water;
II
(MET.
on
oral
(250
mg/kg)
daily;
III
(DOX.
alternate
day
intraperitoneal
Doxorubicin
(3
totaling
18
mg/kg;
IV
MET.
received
both
daily
mg/kg).
microbial
analysis
was
made
from
stool
before
animals
sacrificed
for
biochemical
analysis.
Significant
alterations
observed
ɑ
β-diversity
new
genus
Firmicutes,
specifically
Clostridia_UCG-014,
Eubacterium
ruminantium,
Tunicibacter,
prevalent
the
DOX.
Control
DOX.MET
groups.
Proteobacteria,
represented
by
Succinivibrio,
absent
all
Additionally,
Parabacteroides
Bacteroidia
phylum
except
N.
control.
In
group,
levels
Angiotensin
(
7.75±
0.49
nmol/min,
p<0.01)
Renin
(2.60±0.26
ng/ml/hr)
significantly
reduced.
Conversely,
CK-MB,
Fibrinogen,
Troponin,
CRP
p
<
0.0001),
TNFɑ
(p
0.05)
elevated.
Histopathological
examination
revealed
substantial
cardiac
changes,
including
Fibrinogen
fat
deposition
eosinophilic
infiltration,
as
well
liver
damage
characterized
binucleated
cells
damaged
hepatocytes,
altered
renal
tissues
DOX.MET.Control
group.
The
findings
suggest
that
modifies
gut
microbiota,
particularly
impacting
Firmicutes
Proteobacteria
phyla.
reduction
levels,
alongside
increased
inflammatory
markers
myocardial
damage,
highlights
complex
interactions
potential
adverse
effects
associated
MET
therapy
health.
Language: Английский
Metabolic insights into gut microbiota in the pharmacology of natural medicines
Zixin Chen,
No information about this author
Junchi Zhou,
No information about this author
Xiao Zheng
No information about this author
et al.
Chinese Journal of Natural Medicines,
Journal Year:
2025,
Volume and Issue:
23(2), P. 158 - 168
Published: Feb. 1, 2025
Language: Английский
Effects of Ginsenoside Rb1 on the Crosstalk between Intestinal Stem Cells and Microbiota in a Simulated Weightlessness Mouse Model
Beibei Zong,
No information about this author
Jingyi Wang,
No information about this author
K. Wang
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(16), P. 8769 - 8769
Published: Aug. 12, 2024
Exposure
to
the
space
microenvironment
has
been
found
disrupt
homeostasis
of
intestinal
epithelial
cells
and
alter
composition
microbiota.
To
investigate
this
in
more
detail
examine
impact
ginsenoside
Rb1,
we
utilized
a
mouse
model
hindlimb
unloading
(HU)
for
four
weeks
simulate
effects
microgravity.
Our
findings
revealed
that
HU
mice
had
ileum
injury
with
decrease
number
stem
(ISCs)
level
cell
proliferation.
The
niche
functions
ISCs
were
also
impaired
mice,
including
reduction
Paneth
Wnt
signaling,
along
an
increase
oxidative
stress.
administration
Rb1
during
entire
duration
alleviated
observed
defects,
suggesting
its
beneficial
influence
on
homeostasis.
Hindlimb
resulted
gut
dysbiosis.
supplementation
or
addition
derivative
compound
K
bacterial
culture
vitro
promoted
growth
probiotic
species
such
as
Akkermansia.
co-housing
experiment
further
showed
treatment
ground
control
alone
could
alleviate
defects
co-housed
Rb1-treated
mice.
Together,
these
results
underscore
close
relationship
between
dysbiosis
ISC
model.
It
highlights
mitigating
HU-induced
by
promoting
expansion
probiotics.
These
animal-based
insights
provide
valuable
knowledge
development
improved
approaches
maintaining
astronauts.
Language: Английский